Elite members get real-time data, technical charting, alerts, and no ads - starting at $24.96/mo. Try Elite Free for 7 Days
Login Sign up free
Home Screener Maps Charts News Groups Insider Futures Forex Crypto Portfolio Calendar
Pricing

New feature:   Automatically detect candlestick patterns on any chart

Read How
Market News Market Pulse Stocks News ETF News Crypto News

Caribou Biosciences, Inc.

Contributing Author

Recent Articles by Caribou Biosciences, Inc.

Aug-13
Caribou Biosciences Reports Second Quarter 2026 Financial Results and Provides Business Update CRBU -5.29% GlobeNewswire
Jun-29
Caribou Biosciences to Participate in the H.C. Wainwright 4th Annual Cell Therapy Virtual Conference CRBU +5.36% GlobeNewswire
Jun-11
Caribou Biosciences Reports Long-Term Vispa-cel Data in Second-line Large B Cell Lymphoma at EHA 2026 CRBU -7.26% GlobeNewswire
Jun-11
Caribou Biosciences Reports Dose Escalation Durability Data for CB-011 at the 2026 European Hematology Association (EHA) Annual Meeting CRBU -7.26% GlobeNewswire
May-27
Caribou Biosciences to Participate in the 2026 Jefferies Global Healthcare Conference CRBU +6.94% GlobeNewswire
May-13
Caribou Biosciences to Participate in the H.C. Wainwright 4th Annual BioConnect Investor Conference CRBU GlobeNewswire
May-12
Caribou Biosciences to Highlight Vispa-cel and CB-011 Programs During Oral Presentations at the 2026 European Hematology Association (EHA) Annual Meeting CRBU GlobeNewswire
May-07
Caribou Biosciences Reports First Quarter 2026 Financial Results and Provides Business Update CRBU GlobeNewswire
May-05
Caribou Biosciences to Participate in the BofA Securities 2026 Health Care Conference CRBU GlobeNewswire
Mar-31
Caribou Biosciences Announces the FDA Granted Regenerative Medicine Advanced Therapy (RMAT) Designation to CB-011, an Allogeneic Anti-BCMA CAR-T Cell Therapy CRBU +10.47% GlobeNewswire
Mar-05
Caribou Biosciences Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update CRBU CRBU +6.43% GlobeNewswire
Feb-12
Caribou Biosciences to Participate in Upcoming Investor Conferences CRBU GlobeNewswire
Feb-04
Caribou Biosciences Announces Late-Breaking Presentations at the 2026 Tandem Meetings of ASTCT and CIBMTR CRBU GlobeNewswire
Dec-01
Caribou Biosciences to Host In-Person and Virtual KOL Event at ASH 2025 CRBU -8.76% GlobeNewswire
Nov-12
Caribou Biosciences Reports Third Quarter 2025 Financial Results and Provides Business Update CRBU CRBU -12.17% GlobeNewswire
Nov-03
Caribou Biosciences to Participate in Upcoming Investor Conferences CRBU CRBU -10.70% GlobeNewswire
Nov-03
Caribou Biosciences Announces Positive Data from CaMMouflage Phase 1 Trial of CB-011 in Multiple Myeloma CRBU GlobeNewswire
Nov-03
Caribou Biosciences Announces Positive Data from ANTLER Phase 1 Trial Demonstrating Efficacy and Durability of Vispa-cel (CB-010), an Allogeneic CAR-T Cell Therapy, on Par with Autologous CAR-T Cell Therapies CRBU GlobeNewswire
Nov-02
Caribou Biosciences to Host Webcast to Report New Data Updates from Two Allogeneic CAR-T Cell Therapy Programs in Lymphoma and Multiple Myeloma CRBU GlobeNewswire
Aug-25
Caribou Biosciences to Participate in the Citi 2025 Biopharma Back to School Conference CRBU CRBU +6.38% GlobeNewswire
Aug-12
Caribou Biosciences Reports Second Quarter 2025 Financial Results and Provides Business Update CRBU CRBU +8.94% GlobeNewswire
May-28
Caribou Biosciences to Participate in the Jefferies Global Healthcare Conference CRBU GlobeNewswire
May-08
Caribou Biosciences Reports First Quarter 2025 Financial Results and Provides Business Update CRBU GlobeNewswire
May-06
Caribou Biosciences to Participate in the BofA Securities 2025 Health Care Conference CRBU -12.16% GlobeNewswire
Affiliate • Advertise • API and Exports • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information
Stock quotes delayed by 1 minute. Futures and options delayed by 15 minutes.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)